Versigent Ltd 8-K

What Happened
Versigent Ltd (VGNT) announced on March 23, 2026 that its board appointed Paul Meister as a director, increasing the board from two to three members; the appointment is effective March 27, 2026 at 9:00 a.m. ET. The company expects Mr. Meister to become non‑executive Chair as of and following the previously announced spin‑off of Versigent from Aptiv, which is expected to be effective April 1, 2026 at 12:01 a.m. New York time. Upon the spin‑off, the company will convert to a public limited company and be renamed Versigent PLC.

Key Details

• Board and committees: Board size increases from 2 to 3; Mr. Meister will join the Audit Committee, Compensation & Human Resources Committee, and Nominating & Governance Committee.
• Qualifications: Board determined Mr. Meister is an independent director, is financially literate, qualifies as an “audit committee financial expert,” and meets Rule 10A‑3 requirements.
• Compensation and holdings: Expected annual non‑employee director compensation of $300,000 (cash and time‑based RSUs) plus an additional $185,000 cash retainer as non‑executive Chair. He may elect to receive 60%, 80% or 100% of annual pay in RSUs. He must hold $600,000 in ordinary shares within five years.
• Timing: Appointment effective March 27, 2026; spin‑off (Distribution Date) expected April 1, 2026; RSU grants generally made at the annual shareholder meeting (special timing rules apply in the spin‑off year).

Why It Matters
This filing signals board strengthening and governance preparations as Versigent separates from Aptiv and becomes a publicly listed PLC. Adding an independent director who is an audit committee financial expert can help satisfy NYSE/SEC governance requirements and support financial oversight expected of a public company. Investors should note the compensation, equity holding requirement, and that the chair appointment is tied to the spin‑off—completion and timing of which remain subject to the risks and conditions described in the company’s filings.